Literature DB >> 27805821

Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin.

Pengfei Zhou1, Yan Liu2, Lu Zhou1, Kongkai Zhu2, Kechang Feng1, Hao Zhang2, Yuru Liang1, Hualiang Jiang2, Cheng Luo2, Mingming Liu1, Yang Wang1.   

Abstract

A series of chiral β-lactam bridged analogues (3-substituted 1,4-diaryl-2-azetidinones) of combretastatin A-4 (CA-4) were synthesized asymmetrically, and their antitumor activities were evaluated in vitro and in vivo. The cocrystal structure of tubulin in complex with compound 9 was determined by X-ray crystallography, which showed that 9 binds to the same site as colchicine with similar binding mode, and the absolute configuration of its C-4 was first identified and demonstrated to be critically important for their antiproliferative activities.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27805821     DOI: 10.1021/acs.jmedchem.6b01268

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.

Authors:  Zaki S Seddigi; M Shaheer Malik; A Prasanth Saraswati; Saleh A Ahmed; Ahmed O Babalghith; Hawazen A Lamfon; Ahmed Kamal
Journal:  Medchemcomm       Date:  2017-07-04       Impact factor: 3.597

Review 2.  Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.

Authors:  Jiaxing Wang; Duane D Miller; Wei Li
Journal:  Drug Discov Today       Date:  2021-12-08       Impact factor: 7.851

3.  Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors.

Authors:  Shewei Guo; Yingwei Zhen; Mengguo Guo; Longzhou Zhang; Guosheng Zhou
Journal:  Invest New Drugs       Date:  2018-07-18       Impact factor: 3.850

4.  High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design.

Authors:  Oskía Bueno; Juan Estévez Gallego; Solange Martins; Andrea E Prota; Federico Gago; Asier Gómez-SanJuan; María-José Camarasa; Isabel Barasoain; Michel O Steinmetz; J Fernando Díaz; María-Jesús Pérez-Pérez; Sandra Liekens; Eva-María Priego
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

5.  Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors.

Authors:  Qile Xu; Kai Bao; Maolin Sun; Jingwen Xu; Yueting Wang; Haiqiu Tian; Daiying Zuo; Qi Guan; Yingliang Wu; Weige Zhang
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

6.  A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of Approval.

Authors:  Sacnicte Ramirez-Rios; Sophie Michallet; Leticia Peris; Caroline Barette; Clotilde Rabat; Yangbo Feng; Marie-Odile Fauvarque; Annie Andrieux; Karin Sadoul; Laurence Lafanechère
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

7.  Structural Basis of Colchicine-Site targeting Acylhydrazones active against Multidrug-Resistant Acute Lymphoblastic Leukemia.

Authors:  Nathália Moreno Cury; Tobias Mühlethaler; Angelo Brunelli Albertoni Laranjeira; Rafael Renatino Canevarolo; Priscila Pini Zenatti; Daniel Lucena-Agell; Isabel Barasoain; Chunhua Song; Dongxiao Sun; Sinisa Dovat; Rosendo Augusto Yunes; Andrea Enrico Prota; Michel Olivier Steinmetz; José Fernando Díaz; José Andrés Yunes
Journal:  iScience       Date:  2019-10-02

8.  Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents.

Authors:  Ming-Yu Song; Qiu-Rui He; Yi-Lin Wang; Hao-Ran Wang; Tian-Cheng Jiang; Jiang-Jiang Tang; Jin-Ming Gao
Journal:  Int J Mol Sci       Date:  2020-03-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.